Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting

BACKGROUND: As indications for immune checkpoint inhibitor (ICI) therapy have increased in recent years, so has the proportion of patients eligible for this type of therapy. However, a lack of data exists about the risks and benefits of ICI therapy in hospitalized patients, who tend to be frailer an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Durbin, Sienna M., Zubiri, Leyre, Niemierko, Andrzej, Bardia, Aditya, Sullivan, Ryan J., McEwen, Corey, Mulvey, Therese M., Allen, Ian M., Lawrence, Donald P., Cohen, Justine V., Hochberg, Ephraim P., Ryan, David P., Petrillo, Laura A., Reynolds, Kerry L.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Immuno‐Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794195/
https://ncbi.nlm.nih.gov/pubmed/33044765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13561
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados